Carboplatin

Posted on: March 18, 2024 *Updated on: May 27, 2024

---

Carboplatin is a chemotherapy drug that’s part of the platinum-based anti-cancer drug category, which also includes cisplatin. These drugs function by causing DNA damage within cancer cells, which inhibits their ability to divide and grow, leading to cell death. Carboplatin is often considered a more manageable option compared to cisplatin, mainly because it tends to produce fewer and less severe side effects, making it a more suitable option for some patients.

The effectiveness of carboplatin, like with many chemotherapy drugs, can vary depending on the type and stage of cancer being treated. Its use in pleural mesothelioma—a type of cancer that affects the lining of the lungs, commonly associated with asbestos exposure—highlights a specific scenario where carboplatin is used in combination with another chemotherapy agent, Alimta (pemetrexed). This combination can be an important treatment approach for managing pleural mesothelioma, aiming to improve survival and life quality for patients.

The median survival is about 13 months for pleural mesothelioma patients treated with Alimta and carboplatin. This reflects the challenging nature of treating this cancer. Mesothelioma is notoriously difficult to manage, in part because it’s often diagnosed at a late stage. In this context, the treatment goals typically focus on extending survival, alleviating symptoms, and improving the patient’s quality of life, rather than curing the disease.

Carboplatin, under its brand name Paraplatin, is administered intravenously and is used in various cancer treatment protocols, including for ovarian, lung, head and neck, and endometrial cancers, among others. Its side effects, while generally milder than those of cisplatin, can include nausea, vomiting, blood count changes (leading to increased risk of infection or anemia), and kidney function changes, among others. Management of these side effects is an important part of the treatment process, ensuring patients can complete their treatment regimen with the best possible quality of life.